top
Search terms
Results 1 - 5 of 5 - ordered by :
Escardio

In the COMPASS trial,(1,2) combined aspirin and rivaroxaban treatment reduced ischaemic events in patients with stable coronary artery disease (CAD) or peripheral artery disease (PAD). In the ...

Date : 02/10/2019
Escardio

Rivaroxaban for stroke or TIA prevention in heart failure patients with sinus rhythm The results of the Commander HF trial about the effects of low dose Rivaroxaban in combination with antiplatelet ...

Date : 08/08/2019
Escardio

Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With ...

Date : 01/06/2019
Escardio

In this trial lower blood pressure was associated with a reduction in cardiovascular events but also associated with a higher percentage of acute renal failure. In a current publication association ...

Date : 01/02/2019
Escardio

Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus ASCEND Study Collaborative Group Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly McNeil JJ ...

Date : 15/11/2018